Digital Contact Tracing for COVID-19: An Analysis of Strengths and Limitations

An article in CMAJ (Canadian Medical Association Journal) analyzes the strengths and limitations of digital contact tracing for people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to help governments decide if and how they might adopt this technology.

"Although the benefits of digital contact tracing may be appealing, in considering whether to adopt these technologies, public health agencies and governments must also consider their technological limitations and the inherent trade-offs between privacy and effectiveness," writes Dr. Robert Kleinman, Stanford University School of Medicine, with his coauthor.

Integrating app-based contract tracing with traditional contact tracing techniques may help leverage benefits and mitigate the limitations of each approach.

Apps must be field tested in real-world situations to understand their ability to identify exposures. To identify significant numbers of contacts, apps need to be adopted by a large proportion of the population. Governments considering digital contact tracing, such as the government of Alberta, should incorporate privacy protection, establish thresholds for exposure identification, encourage widespread adoption of the technology and ensure communication among public health agencies across provincial, state and national borders.

The authors caution that access to widespread, accurate testing for SARS-CoV2, the virus that causes coronavirus disease 2019 (COVID-19), is key to the success of digital contact tracing.

Robert A Kleinman, Colin Merkel.
Digital contact tracing for COVID-19.
CMAJ 2020. doi: 10.1503/cmaj.200922.

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...